Seoul Asan Unveils South Korea's First Dedicated Fetal Heart Center, Redefining High-Risk Pregnancy Care
Context mode is active. Hover over any highlighted term to see its definition. Click a nested term to go deeper.
Seoul Asan Hospital has officially opened South Korea first independent Fetal Heart Center, marking a significant leap forward in specialized care for high-risk pregnancies and congenital heart defects. Unveiled on September 28, this dedicated facility offers a groundbreaking 'one-stop' system, providing comprehensive treatment from early prenatal diagnosis through to postnatal surgery and long-term care. For expectant parents like 35-year-old Ms. Park, whose fetus was diagnosed with a ventricular septal defect after a long IVF journey, this new center offers a vital lifeline and much-needed peace of mind. This initiative builds on Seoul Asan's two decades of pioneering work in fetal medicine, stemming from its original Fetal Treatment Center established in 2004, which has cared for over 30,000 fetuses. The rising incidence of detected fetal heart anomalies, partly due to advanced maternal age and improved prenatal screening technologies, has driven the urgent need for such specialized infrastructure. The Fetal Heart Center brings together a multidisciplinary team of obstetricians, neonatologists, pediatric cardiologists, and pediatric cardiac surgeons, ensuring seamless, coordinated care plans for complex cases that previously faced fragmented treatment pathways. The center plans to further expand its capabilities by introducing advanced fetal interventions, including cutting-edge fetal cardiac catheterization procedures. With its strategic location on the same floor as delivery rooms, operating rooms, and the neonatal intensive care unit, the facility is set to enhance early management and improve success rates for cardiac surgeries in newborns and infants. This pioneering model is poised to set new benchmarks for fetal care across Asia, promising better outcomes for thousands of families facing the daunting challenges of fetal heart conditions.